Participant recruitment and retention in randomised controlled trials of melanoma surveillance: A scoping review
Deonna M. Ackermann, Karen Bracken, Jolyn K. Hersch, Monika Janda, Robin M. Turner, Katy J.L. Bell

TL;DR
This study reviews how participants are recruited and retained in trials for melanoma surveillance, highlighting gaps in reporting and effectiveness data.
Contribution
The study provides a comprehensive overview of recruitment and retention practices in melanoma surveillance trials, emphasizing the need for better reporting standards.
Findings
Trials reported recruitment rates of 63% on average, with wide variation across studies.
Retention rates averaged 85%, but few studies evaluated the effectiveness of their strategies.
Common strategies included targeted identification and financial incentives, though reporting was inconsistent.
Abstract
This scoping review aims to collate and describe data on recruitment, retention, and strategies used to improve these, in randomised controlled trials of melanoma surveillance. We searched MEDLINE, EMBASE, CINAHL and CENTRAL databases from inception until October 23, 2023. Two reviewers screened titles and abstracts, and full-texts, and one reviewer extracted data (convenience sample (n = 5) checked by a second). Eligibility criteria included: (i) RCT design, (ii) clinical setting, (iii) participants at increased risk of melanoma, (iv) interventions for early melanoma detection, and (v) early detection outcomes or surrogates such as improved skin self-examination. We calculated summary statistics and undertook qualitative data synthesis. From 1746 records, 21 trials (reported in 28 papers) were included. Recruitment sources included dermatology clinics, general practice sites, and…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealth Systems, Economic Evaluations, Quality of Life · Ethics in Clinical Research · Sex and Gender in Healthcare
